NAD+ vs Methylene Blue

NAD+ wins for:

• Direct restoration of cellular NAD+ pools, targeting age/stacker-induced depletion.
• Post-cycle recovery (liver/mitochondria), sirtuin/PARP activation, and endurance enhancement.
• Compatibility with nearly all compounds—no pharmacologic interactions or serotonin risk.

Methylene Blue wins for:

• Rapid, perceptible CNS effects (focus, cognition) at low physiological doses (microgram–low milligram).
• Functioning as a mitochondrial electron cycler—works even when respiratory chain (complex I/III) is damaged.
• Oral, sublingual, and topical delivery are all reasonably bioavailable and side-effect profile is highly dose-dependent (simple to titrate).

Pick NAD+ if:

• You need to directly replenish depleted NAD+ from age, hard cycles, or high metabolic stress (especially for recovery, endurance, or overall mitochondrial health).
• You're stacking for longevity (NAD+ + NR/NMN + rapamycin) and want a 'restore from first principles' approach.
• You're coming off heavy oral AAS cycles and want to accelerate mitochondrial and hepatic repair.
• You want a zero-interaction protocol: you're running other serotonergic or MAOI agents and can't risk pharmacologic conflict.
• You can tolerate injections or IVs and want something compatible with other anti-aging/longevity stacks.

Pick Methylene Blue if:

• You want a tangible, quick cognitive boost or neuroprotective effect with oral/sublingual dosing—MB's impact on energy and attention is both real and fast.
• Your focus is improving mitochondrial output even in the presence of mitochondrial damage (e.g., after neuroinflammation, chronic fatigue, or aging-related respiration drops).
• You're stacking with red light (photobiomodulation), leveraging the MB-cox synergy for cognitive or resilience goals.
• You need to avoid injections/IVs and prefer oral or sublingual routes.
• You're NOT running SSRIs, SNRIs, MAOIs, or serotonergic agents (serotonin syndrome risk is real).